Helios Klinik Ambrock
Hagen, North Rhine-Westphalia, 58091, Germany
NCT Number: NCT02399514
Improvement of sleep quality in emphysema patients is desirable. Yet, there are no data of patients treated with RePneu coils. This monocenter prospective study investigates the effect on sleep quality of RePneu coils for reduction of dynamic hyperinflation in advanced disease stages of pulmonary emphysema.
Patient's sleep will be studied in three Polysomnography measurement nights, one prior to Coil Treatment, one six months after, and one twelve month after.
Primary objective is to investigate differences in sleep quality 6 and 12 months after Coil Treatment.
Further endpoints are changes in daily activity and sleep (actigraphy), 6MWT, lung function parameters, and questionnaires (SGRQ, mMRC dyspnoe scale).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hagen, North Rhine-Westphalia, 58091, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Polysomnographic diagnostic performed one prior to Coil Treatment, one six months after and one twelve month after Coil Treatment
Other names: PSG
Time frame: 3 times in one year
Sleep Efficiency is evaluated by the ratio of WASO (Time "wake after sleep onset") to Sleep Period Time (SPT).
Time frame: 3 times in one year
The St. George Respiratory Questionnaire (SGRQ) is designed to capture the health related quality of life.
Time frame: 1 week in baseline and 6 month after coil treatment
Institut für Pneumologie Hagen Ambrock eV
Industry
Verbesserung Der Schlafqualität Durch RePneu® Coils Zur Behandlung Des Fortgeschrittenen Lungenemphysems
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05567562
COPD, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT06826560
Behavior, Bronchial Diseases
Warsaw, Poland
View Trial DetailsNCT04559464
COPD, Chronic Disease
Brisbane, Australia
View Trial DetailsNCT04256408
COPD, Chronic Disease
Groningen, Netherlands
View Trial Details